ACRX AcelRx Pharmaceuticals, Inc. Stock Quote

ACRX [NASD]

Healthcare | Drug Manufacturers - Specialty & Generic | USA

Index	-	P/E	-	EPS (ttm)	-0.56	Insider Own	1.20%	Shs Outstand	113.81M	Perf Week	1.06%
Market Cap	224.33M	Forward P/E	-	EPS next Y	-0.26	Insider Trans	0.00%	Shs Float	88.69M	Perf Month	-13.18%
Income	-45.90M	PEG	-	EPS next Q	-0.10	Inst Own	25.80%	Short Float	8.81%	Perf Quarter	25.66%
Sales	5.20M	P/S	43.14	EPS this Y	16.70%	Inst Trans	29.11%	Short Ratio	1.35	Perf Half Y	55.28%
Book/sh	-0.66	P/B	-	EPS next Y	45.80%	ROA	-60.70%	Target Price	-	Perf Year	38.41%
Cash/sh	0.37	P/C	5.20	EPS next 5Y	-	ROE	85.50%	52W Range	0.70 - 2.94	Perf YTD	54.03%
Dividend	-	P/FCF	-	EPS past 5Y	2.60%	ROI	340.90%	52W High	-35.37%	Beta	0.98
Dividend %	-	Quick Ratio	2.80	Sales past 5Y	-15.20%	Gross Margin	-23.20%	52W Low	170.89%	ATR	0.23
Employees	25	Current Ratio	2.90	Sales Q/Q	133.30%	Oper. Margin	-	RSI (14)	43.15	Volatility	7.36% 9.57%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	36.60%	Profit Margin	-	Rel Volume	0.45	Prev Close	1.91
Shortable	Yes	LT Debt/Eq	-	Earnings	-	Payout	-	Avg Volume	5.80M	Price	1.90
Recom	2.20	SMA20	-15.29%	SMA50	-0.28%	SMA200	24.90%	Volume	1,223,508	Change	-0.52%

Jul-20-20

Downgrade

Credit Suisse

Neutral → Underperform

Nov-11-19

Downgrade

Credit Suisse

Outperform → Neutral

$7 → $2

Aug-05-19

Resumed

Credit Suisse

Outperform

Jul-10-19

Resumed

Credit Suisse

Outperform

Apr-24-19

Resumed

B. Riley FBR

Buy

$6.50

Feb-15-19

Initiated

Credit Suisse

Outperform

Oct-23-18

Initiated

B. Riley FBR

Buy

Oct-13-17

Reiterated

RBC Capital Mkts

Outperform

$6 → $5

Oct-13-17

Downgrade

Jefferies

Buy → Hold

Jul-14-17

Resumed

Jefferies

Buy

Sep-15-16

Reiterated

ROTH Capital

Buy

$11.25 → $15

Aug-05-16

Downgrade

Stifel

Buy → Hold

Oct-30-15

Upgrade

Jefferies

Hold → Buy

Oct-05-15

Reiterated

ROTH Capital

Buy

$8.50 → $10.50

Sep-02-15

Initiated

H.C. Wainwright

Buy

$8.50

Jul-10-15

Resumed

ROTH Capital

Buy

$7.50

May-06-15

Reiterated

Mizuho

Neutral

$5.50 → $3

May-05-15

Reiterated

RBC Capital Mkts

Outperform

$8 → $7

Mar-10-15

Reiterated

RBC Capital Mkts

Outperform

$12 → $8

Mar-09-15

Downgrade

Mizuho

Buy → Neutral

$14 → $5.59

Mar-03-21 03:00AM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AcelRx Pharmaceuticals, Inc. (ACRX) PR Newswire
Feb-22-21 01:46PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AcelRx Pharmaceuticals, Inc. (ACRX) Newsfile
Feb-20-21 07:00PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AcelRx Pharmaceuticals, Inc. (ACRX) ACCESSWIRE
Feb-18-21 09:47PM	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AcelRx Pharmaceuticals, Inc. (ACRX) PR Newswire
Feb-17-21 08:30AM	AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Patients Undergoing Plastic Surgery Procedures PR Newswire
Feb-04-21 11:40PM	When Will AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Become Profitable? Simply Wall St.
Jan-26-21 10:04AM	ROCE Insights For AcelRx Pharmaceuticals Benzinga
Jan-20-21 09:00AM	AcelRx Announces Pricing of $27.5 Million Public Offering of Common Stock PR Newswire -17.02%
Jan-19-21 04:01PM	AcelRx Announces Underwritten Public Offering of Common Stock PR Newswire +12.98%
08:30AM	AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Cardiac Surgery Enhanced Recovery Regimen PR Newswire
Jan-14-21 08:30AM	AcelRx Announces Year-End 2020 Metrics and Review of 2020 Achievements PR Newswire -6.53%
Jan-13-21 10:30AM	ROCE Insights For AcelRx Pharmaceuticals Benzinga -8.72%
08:40AM	Do Options Traders Know Something About AcelRx (ACRX) Stock We Don't? Zacks
Jan-12-21 11:39AM	These 2 Penny Stocks Could Surge Over 300%, Say Analysts TipRanks +60.29%
Dec-10-20 09:00AM	AcelRx Pharmaceuticals Announces Publication of Clinical Data on Decreased Postoperative Opioid Requirements and Enhanced Postanesthesia Recovery Following Perioperative Use of DSUVIA® PR Newswire
08:30AM	AcelRx Announces $10 Million Registered Direct Common Stock Offering PR Newswire
Dec-09-20 12:20PM	AcelRx Pharmaceuticals to Present at LD Micro Main Event PR Newswire
Dec-04-20 08:30AM	AcelRx Pharmaceuticals Announces Partnership with the National Rural Health Association PR Newswire +6.29%
Dec-02-20 10:58AM	Is AcelRx Pharmaceuticals (ACRX) A Good Stock To Buy Now? Insider Monkey
Nov-18-20 08:30AM	AcelRx Pharmaceuticals Announces Commentary in Practical Pain Management on Previously Published Clinical Data on Preoperative Administration of DSUVIA® PR Newswire
Nov-07-20 07:08AM	Analysts Are Upgrading AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) After Its Latest Results Simply Wall St.
Nov-06-20 01:28PM	AcelRx Pharmaceuticals to Present at Credit Suisse 29th Annual Virtual Healthcare Conference PR Newswire -22.46%
Nov-05-20 08:20PM	AcelRx Pharmaceuticals (ACRX) Reports Q3 Loss, Misses Revenue Estimates Zacks
04:05PM	AcelRx Pharmaceuticals Reports Third Quarter 2020 Financial Results PR Newswire
02:30PM	AcelRx Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Oct-29-20 04:05PM	AcelRx to Host Third Quarter 2020 Financial Results Call and Webcast on Thursday, November 5, 2020 PR Newswire
Oct-28-20 12:33PM	AcelRx Pharmaceuticals (ACRX) May Report Negative Earnings: Know the Trend Ahead of Q3 Release Zacks
Oct-21-20 10:46AM	Aclaris (ACRS) Begins Phase II Study on Eczema Candidate Zacks
Oct-15-20 10:26AM	RedHill's (RDHL) RHB-204 Gets FDA Orphan Drug Designation Zacks -9.19%
Oct-13-20 12:00PM	AcelRx Pharmaceuticals (ACRX) Upgraded to Buy: Here's Why Zacks
08:44AM	AcelRx (ACRX) Looks Good: Stock Adds 5.3% in Session Zacks
Oct-12-20 08:59AM	Is the Options Market Predicting a Spike in AcelRx (ACRX) Stock? Zacks +5.32%
Sep-29-20 08:30AM	AcelRx to Host Virtual KOL Event on Perioperative Use of DSUVIA® PR Newswire -6.54%
Sep-23-20 06:48AM	Reflecting on AcelRx Pharmaceuticals' (NASDAQ:ACRX) Share Price Returns Over The Last Three Years Simply Wall St. -13.31%
Sep-22-20 08:30AM	AcelRx Awarded U.S. Army Contract for DSUVIA® PR Newswire
Sep-14-20 08:30AM	AcelRx Announces DSUVIA® Added to the U.S. Department of Defense's Joint Deployment Formulary PR Newswire +17.76%
Sep-10-20 04:05PM	AcelRx Pharmaceuticals to Present at Two Upcoming Conferences PR Newswire -5.22%
Aug-31-20 05:00PM	LD Micro - 360 Companies Set to Present this Week ACCESSWIRE
Aug-24-20 08:30AM	AcelRx Announces an Investigator-Initiated Study of DSUVIA® in Orthopedic Patients in the Perioperative Setting PR Newswire -7.30%
Aug-19-20 08:30AM	AcelRx Pharmaceuticals Announces Publication of Clinical Data on Reduced Opioid Use and Reduced Time in the Postanesthesia Care Unit (PACU) Following Preoperative Administration of DSUVIA® PR Newswire +14.52%
Aug-11-20 12:00PM	AcelRx Pharmaceuticals (ACRX) Moves to Buy: Rationale Behind the Upgrade Zacks -11.59%
Aug-10-20 05:45PM	AcelRx Pharmaceuticals (ACRX) Reports Q2 Loss, Lags Revenue Estimates Zacks
04:01PM	AcelRx Pharmaceuticals Reports Second Quarter 2020 Financial Results PR Newswire
Aug-03-20 04:05PM	AcelRx to Host Second Quarter 2020 Financial Results Call and Webcast on Monday, August 10th, 2020 PR Newswire
Jul-27-20 12:31PM	Earnings Preview: AcelRx Pharmaceuticals (ACRX) Q2 Earnings Expected to Decline Zacks +5.93%
Jul-25-20 08:02AM	New Forecasts: Here's What Analysts Think The Future Holds For AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Simply Wall St.
Jul-23-20 08:40AM	AcelRx Announces Exclusive Distribution and Promotion Partnership for DSUVIA® PR Newswire +5.66%
08:30AM	AcelRx Announces $10 Million Common Stock Offering Priced At The Market PR Newswire
Jun-22-20 10:11PM	Edited Transcript of ACRX.OQ earnings conference call or presentation 11-May-20 8:30pm GMT Thomson Reuters StreetEvents
Jun-17-20 06:33AM	Trade Alert: The Independent Chairman Of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), Adrian Adams, Has Just Spent US$129k Buying 133% More Shares Simply Wall St.
Jun-08-20 02:45PM	Edited Transcript of ACRX earnings conference call or presentation 16-Mar-20 12:30pm GMT Thomson Reuters StreetEvents +7.24%
Jun-04-20 08:13AM	The Daily Biotech Pulse: Positive Readout For Kezar, AstraZeneca Stitches Oncology Partnership, D-Day For Merck's Triple Combo Antibiotic Benzinga
Jun-03-20 06:50PM	AcelRx Pharmaceuticals Announces It Will Not Further Revise Its Offer to Acquire Tetraphase PR Newswire
Jun-01-20 08:00PM	AcelRx Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference PR Newswire -8.63%
May-29-20 02:34PM	Hedge Funds Have Never Been Less Bullish On AcelRx Pharmaceuticals Inc (ACRX) Insider Monkey -7.33%
08:30AM	AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase PR Newswire
May-27-20 09:54AM	AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase PR Newswire -5.18%
May-12-20 03:00AM	AcelRx Pharmaceuticals Inc (ACRX) Q1 2020 Earnings Call Transcript Motley Fool -9.47%
May-11-20 06:45PM	AcelRx Pharmaceuticals (ACRX) Reports Q1 Loss, Misses Revenue Estimates Zacks +9.03%
04:01PM	AcelRx Pharmaceuticals Reports First Quarter 2020 Financial Results PR Newswire
May-10-20 03:40PM	The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight Benzinga
May-08-20 12:00PM	All You Need to Know About AcelRx Pharmaceuticals (ACRX) Rating Upgrade to Buy Zacks
09:09AM	Is a Beat in Store for Sunoco (SUN) This Earnings Season? Zacks
May-07-20 12:55PM	Bidding War Sends Tetraphase Shares Soaring Benzinga
May-06-20 12:30PM	AcelRx Pharmaceuticals (ACRX) Expected to Beat Earnings Estimates: Should You Buy? Zacks
May-05-20 12:51PM	Tetraphase (TTPH) to Post Q1 Earnings: What's in the Cards? Zacks -6.62%
May-04-20 04:35PM	AcelRx to Host First Quarter 2020 Financial Results Call and Webcast on Monday, May 11th, 2020 PR Newswire
May-02-20 08:08AM	One Thing To Remember About The AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Share Price Simply Wall St.
Apr-30-20 06:00AM	AcelRx Announces DSUVIA® Milestone C Approval and Provides Business Update PR Newswire
Apr-24-20 06:11AM	Bet on Rising P/E Investing With These Top 5 Stocks Zacks
Apr-23-20 09:09AM	AcelRx's Shares March Higher, Can It Continue? Zacks
Apr-16-20 12:02PM	3 Compelling Penny Stocks With at Least 50% Upside Potential TipRanks
Apr-02-20 12:28PM	The Zacks Analyst Blog Highlights: AcelRx, BioCryst, Build-A-Bear, CACI and Evercore Zacks
Apr-01-20 08:18AM	After a Brutal Q1, Q2 Gives a Ray of Hope: 5 Must Buys Zacks -12.71%
Mar-27-20 12:00PM	All You Need to Know About AcelRx Pharmaceuticals (ACRX) Rating Upgrade to Buy Zacks
Mar-18-20 06:05AM	AcelRx Pharmaceuticals, Inc. Just Reported, And Analysts Assigned A US$6.40 Price Target Simply Wall St. -12.64%
Mar-17-20 05:50PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Merger of Tetraphase Pharmaceuticals, Inc. with AcelRx Pharmaceuticals, Inc. is Fair to TTPH Shareholders ACCESSWIRE +13.49%
01:47PM	SHAREHOLDER ALERT: WeissLaw LLP Investigates Tetraphase Pharmaceuticals, Inc. PR Newswire
Mar-16-20 05:10PM	TETRAPHASE PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Merger ACCESSWIRE -18.46%
09:02AM	AcelRx Pharmaceuticals: Q4 Earnings Insights Benzinga
07:35AM	AcelRx Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results PR Newswire
07:30AM	AcelRx Pharmaceuticals to Acquire Tetraphase Pharmaceuticals PR Newswire
Mar-11-20 07:50PM	AcelRx to Announce Fourth Quarter 2019 Results on Monday, March 16th, 2020 PR Newswire
Mar-10-20 02:25PM	AcelRx Announces Confirmed Timing of Department of Defense Milestone C Meeting for April PR Newswire
Mar-06-20 11:55AM	AcelRx Announces Agreement for an Investigator-Initiated Study of DSUVIA® in Patients Undergoing Spine Surgery PR Newswire
Feb-27-20 12:30PM	Earnings Preview: AcelRx Pharmaceuticals (ACRX) Q4 Earnings Expected to Decline Zacks
Feb-24-20 10:28AM	AcelRx (ACRX) to Report Q4 Earnings: What's in the Cards? Zacks
Feb-07-20 06:49AM	Should You Worry About AcelRx Pharmaceuticals, Inc.'s (NASDAQ:ACRX) CEO Salary Level? Simply Wall St.
Jan-27-20 05:45PM	AcelRx Pharmaceuticals (ACRX) Stock Moves -1.14%: What You Should Know Zacks
Jan-13-20 05:50PM	AcelRx Pharmaceuticals (ACRX) Stock Sinks As Market Gains: What You Should Know Zacks
07:00AM	AcelRx Announces Year-End 2019 Metrics and Provides Corporate Updates PR Newswire
Jan-07-20 10:21AM	Soleno (SLNO) Ends Enrollment in Prader-Willi Syndrome Study Zacks
09:51AM	Intrexon's Blood Cancer Drug Gets Orphan Drug Status From FDA Zacks
09:17AM	Catalyst Gives Preliminary Firdapse Estimates & Other Updates Zacks
Jan-06-20 06:38AM	Have Faith in Rising P/E: Play 5 Top-Ranked Stocks Zacks
Jan-03-20 12:00PM	AcelRx Pharmaceuticals (ACRX) Upgraded to Strong Buy: What Does It Mean for the Stock? Zacks
09:07AM	Top Ranked Momentum Stocks to Buy for January 3rd Zacks
Dec-31-19 11:05AM	Jazz Enrolls First Patient in Phase II/III Leukemia Study Zacks
Dec-30-19 05:21AM	How Much Are AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Insiders Spending On Buying Shares? Simply Wall St. -5.36%
Dec-20-19 05:46PM	Is AcelRx Pharmaceuticals Inc (ACRX) A Good Stock To Buy? Insider Monkey

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. The company's lead product candidate is DSUVIA, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. It also develops ZALVISO, a pre-programmed and patient-controlled analgesia system that allows hospital patients with moderate-to-severe acute pain to self-dose with sufentanil sublingual tablets to manage their pain. The company was formerly known as SuRx Pharmaceuticals, Inc. and changed its name to AcelRx Pharmaceuticals, Inc. in August 2006. AcelRx Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Redwood City, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Angotti Vincent J.	Chief Executive Officer	Jun 15	Buy	1.33	7,547	10,035	468,757	Jun 15 06:00 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience